An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: A HuGE review

Prostate

Volumn 69, Issue 6, 2009, Pages 662-688

  Mo, Zengnan ^a   Gao, Yong ^a   Cao, Yunfei ^a   Gao, Feng ^a   Jian, Lijuan ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Glutathione transferase; GSTM1; Gstp1; genetic polymorphism; GSTT1; Prostate cancer; Susceptibility

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GSTP1 PROTEIN, HUMAN;

AFRICA; ARTICLE; ASIAN; CAUCASIAN; CONFIDENCE INTERVAL; DNA POLYMORPHISM; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; AMINO ACID SUBSTITUTION; CARCINOMA; ENZYMOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; MALE; MORTALITY; PROSTATE TUMOR; REVIEW;

AMINO ACID SUBSTITUTION; CARCINOMA; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; MALE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS;

EID: 65549109795     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20907     Document Type: Article

References (92)

1. Hayes J, Pulford D. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprevention and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
2. Rushmore TH, Pickett CB. Glutathione S-transferases, structure, regulation, and therapeutic implications. J Biol Chem 1993;268:11475-11478.
3. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-743. (Pubitemid 27427630)
4. Hayes JD, Strange RC. Glutathione S-transferases polymorphisms and their biological consequence. Pharmacology 2000;61:154-166.
5. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxtcol 2005;45:51-88. (Pubitemid 40261798)
6. Zhong S, Howie A, Ketterer B, Wolf CR, Spurr NK. Glutathione S-transferases mu locus: Use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 1991;12:1533-1537.
7. Bruhn C, Brockmoller J, Kerb R, et al. Concordance between enzyme activity and genotype of glutathione S-transferase theta (GSTT1). Biochem Pharmacol 1998;56:1189-1193.
8. Ali-Osman F, Akande O, Antoun G, Roots I, Borchert HH. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione s-transferases Pi gene variants: Ecidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997;272:10004-10012.
9. Hengstler J, Arand M, Herrero ME, Oesch F. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: Influence on cancer susceptibility. Recent Results Cancer Res 1998;154:46-85.
10. Pemble S, Schroeder K, Spencer S, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271-276. (Pubitemid 24151046)
11. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. Human glutathione S-transferases P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998;19:275-280.
12. Katoh T, Yamano Y, Tsuji M, Watanabe M. Genetic polymorphisms of human cytosol glutathione S-transferases and prostate cancer. Pharmacogenomis 2008;9:93-104.
13. Strange RC, Fryer AA. The glutathione s-transferases: Influence of polymorphism on cancer susceptibility. In: Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P, editors. Metabolic polymorphisms and susceptibility to cancer. Lyon: IARC; 1999. pp 231-249.
14. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: A review. Mutat Res 2000;463:247-283.
15. Gibbs GW, Amsel J, Soden K. A cohort mortality study of cellulose triacetatefiber workers exposed to methylene chloride. J Occup Environ Med 1996;38:693-697. (Pubitemid 26251385)
16. Hecht S. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-1210. (Pubitemid 29357186)
17. Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, Awasthi S, Awasthi YC. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymatic properties. Eur J Biochem 1994;224:893-899. (Pubitemid 24288851)
18. Hu X, Xia H, Srivastava SK, Herzog C, Awasthi YC, Ji X, Zimniak P, Singh SV. Activity of four allelic forms of glutathione Stransferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun 1997;238:397-402. (Pubitemid 27464396)
19. Weinmann S, Richert-Boe K, Glass AG, Weiss NS. Prostate cancer screening and mortality: A case-control study (United States). Cancer Causes Control 2004;15:133-138.
20. Grönberg H. Prostate cancer epidemiology. Lancet 2003;361:859-864. (Pubitemid 36331852)
21. Dijkman GA, Debruyne FM. Epidemiology of prostate cancer. European Urol 1996;30:281-295. (Pubitemid 26362868)
22. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991;63:963-966.
23. Tsugane S, de Souza JM, Costa, ML Jr, Mirra AP, Gotlieb SL, Laurenti R, Watanabe S. Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil 1969-1978. Cancer Cause Control 1990;1:189-193.
24. Hsing AW, Devesa SS. Trends and patterns of prostate cancer: What do they suggest? Epidemiol Rev 2001;23:3-13.
25. Chen C. Risk of prostate cancer in relation to polymorphisms of metabolic genes. Epidemiol Rev 2001;23:30-35. (Pubitemid 32906611)
26. Boccia S, La Torre G, Gianfagna F, Mannocci A, Ricciardi G. Glutathione S-transferase T1 status and gastric cancer risk: A meta-analysis of the literature. Mutagenesis 2006;21:115-123.
27. Zintzaras E, Ioannidis JP. HEGESMA: Genome search meta-analysis and heterogeneity testing. Bioinformatics 2005;21:3672-3673. (Pubitemid 41264106)
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560. (Pubitemid 37088507)
29. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820-826. (Pubitemid 27465551)
30. Zintzaras E, Chatzoulis DZ, Karabatsas CH, Stefanidis I. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: A meta-analysis. J Hum Genet 2005;50:267-275.
31. Weir BS. Genetic Data Analysis II: Methods for Discrete Population Genetic Data. Sunderland, MA: Sinauer Associates; 1996.
32. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-1101.
33. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634. (Pubitemid 27387172)
34. Fleiss JL, Tytun A, Uray HK. A simple approximation for calulating sample size for comparing independent proportions. Biometrics 1980;36:343-346.
35. Caceres D, Iturrieta J, Acevedo C, Huidobro C, Varela N, Escala M, Quinones L. Gene-gene and gene-environment interactions as modifier factors of prostatic cancer risk: "Acase-only" design study. Rev Med Chil 2004;132:961-970.
36. Ntais C, Polycarpou A, Ioannidis JP. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: A meta-analysis. Cancer Epidemiol Biomakers Prev 2005;14:176-181.
37. Nock NL, Liu X, Cicek MS, Li L, Macarie F, Rybicki BA, Plummer SJ, Maclennan GT, Casey G, Witte JS. Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:756-761.
38. Nelson W, Demarzo A, Deweese T. The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention. Urology 2001;57:39-45.
39. Meiers I, Shanks JH, Bostwick DG. Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: Review 2007. Pathology 2007;39:299-304. (Pubitemid 46897603)
40. Katoh T, Yamano Y, Tsuji M, Watanabe M. Genetic polymorphisms of human cytosol glutathione S-transferases and prostate cancer. Pharmacogenomics 2008;9:93-104.
41. Ning B, Wang C, Morel F, Nowell S, Ratnasinghe DL, Carter W, Kadlubar FF, Coles B. Human glutathione S-transferase A2 polymorphisms: Variant expression, distribution in prostate cancer cases/controls and a novel form. Pharmacogenetics 2004;14:35-44.
42. Coles BF, Kadlubar FF. Human alpha class glutathione S-transferases: Genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol 2005;401:9-42.
43. Roupret M, Hupertan V, Catto JW, Yates DR, Rehman I, Proctor LM, Phillips J, Meuth M, Cussenot O, Hamdy FC. Promoter hypermethylation in circulating blood cells identifies prostate cancer progression. Int J Cancer 2008;122:952-956.
44. Perry AS, Loftus B, Moroose R, Lynch TH, Hollywood D, Watson RW, Woodson K, Lawler M. In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer. Br J Cancer 2007;96:1587-1594.
45. Figer A, Friedman T, Manguoglu AE, Flex D, Vazina A, Novikov I, Shtrieker A, Sidi AA, Tichler T, Sapir EE, Baniel J, Friedman E. Analysis of polymorphic patterns in candidate genes in Israeli patients with prostate cancer. Isr Med Assoc J 2003;5:741-745. (Pubitemid 37369045)
46. Nock NL, Tang D, Rundle A, Neslund-Dudas C, Savera AT, Bock CH, Monaghan KG, Koprowski A, Mitrache N, Yang JJ, Rybicki BA. Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon(PAH) metabolismand conjugation genes and PAH-DNA adducts in prostate tumors differ by race. Cancer Epidemiol Biomarkers Prev 2007;16:1236-1245. (Pubitemid 46984965)
47. Debes JD, Yokomizo A, McDonnell SK, Hebbring SJ, Christensen GB, Cunningham JM, Jacobsen SJ, Tindall DJ, Liu W, Schaid DJ, Thibodeau SN. Gluthatione S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer. Cancer Genet Cytogenet 2004;155:82-86. (Pubitemid 39446618)
48. Cunningham JM, Hebbring SJ, McDonnell SK, Cicek MS, Christensen GB, Wang L, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN. Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer. Cancer Epidemiol Biomarkers Prev 2007;16:969-978. (Pubitemid 46910099)
49. Murata M, Shiraishi T, Fukutome K, Watanabe M, Nagao M, Kubota Y, Ito H, Kawamura J, Yatani R. Cytochrome P4501A1 and glutathione S-transferase M1 genotypes as risk factors for prostate cancer in Japan. Jpn J Clin Oncol 1998;28:657-660. (Pubitemid 128523207)
50. Murata M, Watanabe M, Yamanaka M, Kubota Y, Ito H, Nagao M, Katoh T, Kamataki T, Kawamura J, Yatani R, Shiraishi T. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 2001;165:171-177. (Pubitemid 32244174)
51. Rebbeck TR, Walker AH, Julie M, White DL, Wein AJ, Malkowicz SB. Glutathione S-Transferase-m (GSTM1) and -u (GSTT1) Genotypes in the Etiology of Prostate Cancer. Cancer Epidemiol Biomarkers Prev 1999;8:283-287.
52. Kelada SN, Kardia SL, Walker AH, Wein AJ, Malkowicz SB, Rebbeck TR. The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: Genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev 2000;9:1329-1334.
53. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997;18:641-644. (Pubitemid 28132446)
54. Wadelius M, Autrup JL, Stubbins MJ, Andersson SO, Johansson JE, Wadelius C, Wolf CR, Autrup H, Rane A. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 1999;9:333-340. (Pubitemid 29376377)
55. Autrup JL, Thomassen LH, Olsen JH, Wolf H, Autrup H. Glutathione S-transferases as risk factors in prostate cancer. Eur J Cancer Prev 1999;8:525-832. (Pubitemid 30019692)
56. Steinhoff C, Franke KH, Golka K, Thier R, Romer HC, Rotzel C, Ackermann R, Schulz WA. Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 2000;74:521-526.
57. Shepard TF, Platz EA, Kantoff PW, Nelson WG, Isaacs WB, Freije D, Febbo PG, Stampfer MJ, Giovannucci E. No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: A prospective study. Cancer Epidemiol Biomarkers Prev 2000;9:1267-1268.
58. Gsur A, Haidinger G, Hinteregger S, Bernhofer G, Schatzl G, Madersbacher S, Marberger M, Vutuc C, Micksche M. Polymorphisms of glutathione S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer 2001;95:152-155. (Pubitemid 32477229)
59. Kote-Jarai Z, Easton D, Edwards SM, Jefferies S, Durocher F, Jackson RA, Singh R, Ardern-Jones A, Murkin A, Dearnaley DP, Shearer R, Kirby R, Houlston R, Eeles R. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics. 2001;11:325-330. (Pubitemid 32537406)
60. Luscombe CJ, French ME, Liu S, Saxby MF, Farrell WE, Jones PW, Fryer AA, Strange RC. Glutathione S-transferase GSTP1 genotypes are associated with response to androgen ablation therapy in advanced prostate cancer. Cancer Detect Prev 2002;26:376-380. (Pubitemid 36035383)
61. Beer TM, Evans AJ, Hough KM, Lowe BA, McWilliams JE, Henner WD. Polymorphisms of GSTP1 and related genes and prostate cancer risk. Prostate Cancer and Prostatic Diseases 2002;5:22-27. (Pubitemid 34257303)
62. Jeronimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2002;11:445-450. (Pubitemid 34517939)
63. Nakazato H, Suzuki K, Matsui H, Koike H, Okugi H, Ohtake N, Takei T, Nakata S, Hasumi M, Ito K, Kurokawa K, Yamanaka H. Association of genetic polymorphisms of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. Anticancer Res 2003;23:289-902. (Pubitemid 36969831)
64. Kidd LC, Woodson K, Taylor PR, Albanes D, Virtamo J, Tangrea JA. Polymorphisms in glutathione S-transferase genes (GST-M1 GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study. Eur J Cancer Prev 2003;12:317-320. (Pubitemid 36994087)
65. Nam RK, Zhang WW, Trachtenberg J, Jewett MA, Emami M, Vesprini D, Chu W, Ho M, Sweet J, Evans A, Toi A, Pollak M, Narod SA. Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer. Cancer Epidemiol Biomarkers Prev 2003;12:1429-1437. (Pubitemid 38031745)
66. Acevedo C, Opazo JL, Huidobro C, Cabezas J, Iturrieta J, Quinones Sepulveda L. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people. Prostate 2003;57:111-117. (Pubitemid 37204491)
67. Medeiros R, Vasconcelos A, Costa S, Pinto D, Ferreira P, Lobo F, Morais A, Oliveira J, Lopes C. Metabolic susceptibility genes and prostate cancer risk in a southern European population: The role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms. Prostate 2004;58:414-420.
68. Mao GE, Morris G, Lu QY, Cao W, Reuter VE, Cordon-Cardo C, Dalbagni G, Scher HI, deKernion JB, Zhang ZF. Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detection and Prev 2004;28:368-374.
69. Joseph MA, Moysich KB, Freudenheim JL, Shields PG, Bowman ED, Zhang Y, Marshall JR, Ambrosone CB. Ambrosone cruciferous vegetables, genetic polymorphisms in glutathione S-transferases m1 and t1, and prostate cancer risk. Nutr Cancer 2004;50:206-213.
70. Mittal RD, Srivastava DSL, Mandhani A, Kumar A, Mittal B. Polymorphism of GSTM1 and GSTT1 genes in prostate cancer:A study from North India. Indian J Cancer 2004;41:115-119.
71. Aktas D, Hascicek M, Sozen S, Ozen H, Tuncbilek E. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population. Cancer Genet Cytogenet 2004; 154:81-85. (Pubitemid 39286179)
72. Antognelli C, Mearini L, Talesa VN, Giannantoni A, Mearini E. Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer. Prostate 2005;63:240-251. (Pubitemid 40571058)
73. Komiya Y, Tsukino H, Nakao H, Kuroda Y, Imai H, Katoh T. Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol 2005;131:238-242.
74. Lai MT, Chen RH, Tsai FJ, Wan L, Chen WC. Glutathione S-transferase M1 gene but not insulin-like growth factor-2 gene or epidermal growth factor gene is associated with prostate cancer. Urol Oncol: Semin Original Invest 2005;23:225-229. (Pubitemid 40961933)
75. Caceres DD, Iturrieta J, Acevedo C, Huidobro C, Varela N, Quinones L. Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: Exploring some gene-gene and gene-enviroment interactions. Eur J Epidemiol 2005;20:79-88.
76. Srivastava DSL, Mandhani A, Mittal B, Mittal RD. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. Bjuint Ernat Ional 2005;95:170-173. (Pubitemid 350020890)
77. Guan TY, Li M, Na YQ. Polymorphism of metabolic gene and genetic susceptibility to prostate cancer. Chin J Surg 2005;43:1467-1470.
78. Vijayalakshmi K, Vettriselvi V, Krishnan M, Shroff S, Vishwanathan KN, Jayanth VR, Paul SF. Polymorphisms at GSTM1 and GSTP1 gene loci and risk of prostate cancer in a South Indian population. Asian Pac J Cancer Prev 2005;6:309-314.
79. Yang J, Wu HF, Zhang W, Gu M, Hua LX, Sui YG, Zhang ZD, Zhou JW, Wang XR, Zou C, Qian LX. Polymorphisms of metabolic enzyme genes, living habits and prostate cancer susceptibility. Front Biosci 2006;11:2052-2060. (Pubitemid 43822538)
80. Agalliu I, Langeberg WJ, Lampe JW, Salinas CA, Stanford JL. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men. Prostate 2006;66:146-156.
81. Quinones LA, Irarrázabal1CE, Rojas CR, Orellana CE, Acevedo C, Huidobro C, Varela NE, Caceres DD. Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: An exploratory genotype-environment interaction study. Asian J Androl 2006;8:349-355.
82. Silig Y, Pinarbasi H, Gunes S, Ayan S, Bagci H, Cetinkaya O. Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population. Cancer Invest 2006;24:41-45. (Pubitemid 43247272)
83. Mittal RD, Mishra DK, Mandhani A. Evaluating polymorphic status of glutathione S-transferase genes in blood and tissue samples of prostate cancer patients. Asian Pacific J Cancer Prev 2006;7:444-446.
84. Rybicki BA, Neslund-Dudas C, Nock NL, Schultz LR, Eklund L, Rosbolt J, Bock CH, Monaghan KG. Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism. Cancer Detect Prev 2006;30:412-422.
85. Mallick S, Romana M, Blanchet P, Multigner L. GSTM1 and GSTT1 polymorphisms and the risk of prostate cancer in a Caribbean population of African descent. Urology 2007;69:1165-1169. (Pubitemid 46900959)
86. Li M, Guan TY, Li Y, Na YQ. Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men. Chin Med J (Engl) 2008;121:305-308.
87. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999;28:1-9. (Pubitemid 29086203)
88. Negri E, Foschi R, Talamini R, Montella M, Ramazzotti V, Dal Maso L, Bosetti C, Franceschi S, Zucchetto A, La Vecchia C. Family history of cancer and the risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2441-2444. (Pubitemid 46048302)
89. Yang J, Wu HF, Zhang W, Gu M, Hua LX, Sui YG, Zhang ZD, Zhou JW, Wang XR, Zou C, Qian LX. Polymorphisms of metabolic enzyme genes, living habits and prostate cancer susceptibility. Front Biosci 2006;11:2052-2060. (Pubitemid 43822538)
90. Velicer CM, Kristal A, White E. Alcohol use and the risk of prostate cancer: Results from the VITAL cohort study. Nutr Cancer 2006;56:50-56.
91. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;19:2008-2012.
92. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S. The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Haematol 1993;14:77-87. (Pubitemid 23183740)